164 related articles for article (PubMed ID: 17705416)
1. Osteotropic Peptide that differentiates functional domains of the skeleton.
Wang D; Miller SC; Shlyakhtenko LS; Portillo AM; Liu XM; Papangkorn K; Kopecková P; Lyubchenko Y; Higuchi WI; Kopecek J
Bioconjug Chem; 2007; 18(5):1375-8. PubMed ID: 17705416
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
[TBL] [Abstract][Full Text] [Related]
3. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.
Wang D; Sima M; Mosley RL; Davda JP; Tietze N; Miller SC; Gwilt PR; Kopecková P; Kopecek J
Mol Pharm; 2006; 3(6):717-25. PubMed ID: 17140259
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems.
Wang D; Miller S; Sima M; Kopecková P; Kopecek J
Bioconjug Chem; 2003; 14(5):853-9. PubMed ID: 13129387
[TBL] [Abstract][Full Text] [Related]
6. Selective drug delivery system to bone: small peptide (Asp)6 conjugation.
Kasugai S; Fujisawa R; Waki Y; Miyamoto K; Ohya K
J Bone Miner Res; 2000 May; 15(5):936-43. PubMed ID: 10804024
[TBL] [Abstract][Full Text] [Related]
7. Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice.
Shin HD; Yang KJ; Park BR; Son CW; Jang HJ; Ku SK
Nutrition; 2007; 23(11-12):853-60. PubMed ID: 17884343
[TBL] [Abstract][Full Text] [Related]
8. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.
Verron E; Gauthier O; Janvier P; Pilet P; Lesoeur J; Bujoli B; Guicheux J; Bouler JM
Biomaterials; 2010 Oct; 31(30):7776-84. PubMed ID: 20643480
[TBL] [Abstract][Full Text] [Related]
9. Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.
Hengst V; Oussoren C; Kissel T; Storm G
Int J Pharm; 2007 Mar; 331(2):224-7. PubMed ID: 17150316
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.
Singh US; Shankar R; Kumar A; Trivedi R; Chattopadhyay N; Shakya N; Palne S; Gupta S; Hajela K
Bioorg Med Chem; 2008 Sep; 16(18):8482-91. PubMed ID: 18752963
[TBL] [Abstract][Full Text] [Related]
11. The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin.
French DL; Muir JM; Webber CE
Phytomedicine; 2008 Dec; 15(12):1069-78. PubMed ID: 18693096
[TBL] [Abstract][Full Text] [Related]
12. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
Ding M; Danielsen CC; Hvid I
Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
[TBL] [Abstract][Full Text] [Related]
13. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Fukunaga M
Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
[TBL] [Abstract][Full Text] [Related]
14. Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
Leu CT; Luegmayr E; Freedman LP; Rodan GA; Reszka AA
Bone; 2006 May; 38(5):628-36. PubMed ID: 16185944
[TBL] [Abstract][Full Text] [Related]
15. Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation.
Heino TJ; Chagin AS; Takigawa M; Sävendahl L
Bone; 2008 Apr; 42(4):702-9. PubMed ID: 18276203
[TBL] [Abstract][Full Text] [Related]
16. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of PTH and bisphosphonates on the bone healing response to metaphyseal implants in rats.
Aspenberg P; Wermelin K; Tengwall P; Fahlgren A
Acta Orthop; 2008 Feb; 79(1):111-5. PubMed ID: 18283582
[TBL] [Abstract][Full Text] [Related]
18. Mineralised tissues as nanomaterials: analysis by atomic force microscopy.
Bozec L; de Groot J; Odlyha M; Nicholls B; Horton MA
IEE Proc Nanobiotechnol; 2005 Oct; 152(5):183-6. PubMed ID: 16441178
[TBL] [Abstract][Full Text] [Related]
19. Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
Shomali T; Rezaian M; Rassouli A; Asadi F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):46-50. PubMed ID: 19302435
[TBL] [Abstract][Full Text] [Related]
20. [Non-hormonal treatments of postmenopausal osteoporosis].
Malaise O; Neuprez A; Reginster JY
Gynecol Obstet Fertil; 2008; 36(7-8):815-22. PubMed ID: 18653373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
